Re:Almost a third of our portfolio is under attack by patent...
by paraschopra on Tuesday January 12, 2010 @12:20PM
(#1047959)
Actually it will be unwise to generalize for all pharma companies but yes it is a standard practice to license rights from labs/univ
[ Parent
| on HN ]
There are no comments on this comment yet.